Cause of death, by non-communicable diseases, ages 15-59, female in Eritrea
Eritrea: Cause of death, by non-communicable diseases, ages 15-59, female was 53.4% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59, female in Eritrea, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 15-59.
Analysis
Eritrea recorded 53.4% for cause of death, by non-communicable diseases, ages 15-59, female in 2021.
The figure is down 0.7% on the previous year and up 16.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, female in Eritrea peaked at 53.8% in 2020 and was at its lowest, 38.2%, in 2000.
That places Eritrea 120th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59, female in Eritrea, year by year
| Year | % of total female deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 38.2% | — |
| 2010 | 45.8% | +19.9% |
| 2015 | 50.8% | +10.8% |
| 2019 | 53.6% | +5.5% |
| 2020 | 53.8% | +0.4% |
| 2021 | 53.4% | -0.7% |
Eritrea compared with similar countries
- Eritrea's 53.4% is above the median for low income countries, which is 42.6%, 1.3× the median. (25 countries reporting)
- Eritrea's 53.4% is above the median for Sub-Saharan Africa, which is 41.7%, 1.3× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 38.2% | 38.2% | 38.2% | 1 |
| 2010s | 50.0% | 45.8% | 53.6% | 3 |
| 2020s | 53.6% | 53.4% | 53.8% | 2 |
Countries ranked near Eritrea
More health data for Eritrea
- Un projection of annual infant deaths, annual growth rate -1.62 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.2 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 821.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 425 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2011)
- Population ages 00-04, female, per capita 0.0652 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.73 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2011)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, female in Eritrea?
- Cause of death, by non-communicable diseases, ages 15-59, female in Eritrea was 53.4% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, female recorded in Eritrea?
- The highest recorded value was 53.8% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, female recorded in Eritrea?
- The lowest recorded value was 38.2% in 2000.
- How does Eritrea rank for cause of death, by non-communicable diseases, ages 15-59, female?
- Eritrea ranks 120th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, female rising or falling in Eritrea?
- Over the last ten years it is up 16.6%. The long-run trend across the full record is rising.
- Where does this Eritrea data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.